share_log

Biomerica | PRE 14A: Preliminary proxy statements relating to merger or acquisition

Biomerica | PRE 14A: Preliminary proxy statements relating to merger or acquisition

Biomerica | PRE 14A：并购重组委托声明
美股SEC公告 ·  09/20 17:03
Moomoo AI 已提取核心信息
Biomerica, Inc. announced the initiation of a reverse stock split and an increase in authorized shares, subject to stockholder approval. The reverse stock split, at a ratio not less than 1-for-3 and not more than 1-for-15, aims to elevate the per-share trading price to comply with Nasdaq's minimum bid requirement and to attract a broader investor base. The company also seeks to increase authorized common stock from 25 million to 40 million shares, enhancing its ability to raise capital and pursue strategic opportunities. These proposals are part of the agenda for Biomerica's upcoming annual meeting of stockholders, where votes will be cast to determine the outcome. The Board may decide not to proceed with the reverse stock split or the increase in authorized shares if deemed not in the best interest of the company or its stockholders.
Biomerica, Inc. announced the initiation of a reverse stock split and an increase in authorized shares, subject to stockholder approval. The reverse stock split, at a ratio not less than 1-for-3 and not more than 1-for-15, aims to elevate the per-share trading price to comply with Nasdaq's minimum bid requirement and to attract a broader investor base. The company also seeks to increase authorized common stock from 25 million to 40 million shares, enhancing its ability to raise capital and pursue strategic opportunities. These proposals are part of the agenda for Biomerica's upcoming annual meeting of stockholders, where votes will be cast to determine the outcome. The Board may decide not to proceed with the reverse stock split or the increase in authorized shares if deemed not in the best interest of the company or its stockholders.
Biomerica公司宣布启动一项股票拆分和增加已授权股份的程序，需股东批准。股票倒卖拆分比例不低于1比3，不高于1比15，旨在提升每股交易价格，符合纳斯达克的最低买盘要求，并吸引更广泛的投资者群体。该公司还寻求将已授权普通股份从2500万增至4000万股，增强其筹集资本和追求战略机会的能力。这些提案是Biomerica即将召开的股东年度会议议程的一部分，在那里将投票决定结果。如果董事会认为这对公司或股东不利，则可能决定不继续进行股票逆向拆分或增加已授权股份。
Biomerica公司宣布启动一项股票拆分和增加已授权股份的程序，需股东批准。股票倒卖拆分比例不低于1比3，不高于1比15，旨在提升每股交易价格，符合纳斯达克的最低买盘要求，并吸引更广泛的投资者群体。该公司还寻求将已授权普通股份从2500万增至4000万股，增强其筹集资本和追求战略机会的能力。这些提案是Biomerica即将召开的股东年度会议议程的一部分，在那里将投票决定结果。如果董事会认为这对公司或股东不利，则可能决定不继续进行股票逆向拆分或增加已授权股份。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息